High throughput screening for novel enzymes
AssigneeDiversa Corporation, a Delaware corporation
InventorsJay M. Short, Martin Keller
Life of this patent
Estimating the term…
Loading patent…
AssigneeDiversa Corporation, a Delaware corporation
InventorsJay M. Short, Martin Keller
Estimating the term…
Disclosed is a process for identifying clones having a specified activity of interest, which process comprises (i) generating one or more expression libraries derived from nuclei acid directly isolated from the environment; and (ii) screening said libraries utilizing a fluorescence activated cell sorter to identify said clones. More particularly, this is a process for identifying clones having a specified activity of interest by (i) generating one or more expression libraries derived from nucleic acid directly or indirectly isolated from the environment; (ii) exposing said libraries to a particular substrate or substrates of interest; and (iii) screening said exposed libraries utilizing a fluorescence activated cell sorter to identify clones which react with the substrate or substrates. Also provided is a process for identifying clones having a specified activity of interest by (i) generating one or more expression libraries derived from nucleic acid directly or indirectly isolated from the environment; and (ii) screening said exposed libraries utilizing an assay requiring co-encapsulation, a binding event or the covalent modification of a target, and a fluorescence activated cell sorter to identify positive clones.
A method for identifying bioactivities or biomolecules using high throughput screening of nucleic acid comprising:
A method for identifying bioactivities or biomolecules using high throughput screening of nucleic acid comprising:
Dependencies are inferred from the claim text.